Glaukos Corp, 6GJ:FRA profile

Price (EUR)128.00
Today's Change-1.00 / -0.78%
Shares traded20.00
1 Year change+122.61%
Beta--

Data delayed at least 15 minutes, as of Nov 08 2024 07:19 GMT.

More ▼

Add to Your Portfolio

Name

Currency

Profile data is unavailable for this security.

About the company

Glaukos Corporation is an ophthalmic pharmaceutical and medical technology company. It develops novel, dropless therapies and commercializing associated products for the treatment of glaucoma, corneal disorders and retinal disease. Its product candidates include Micro-Invasive Glaucoma Surgery products that involve the insertion of a micro-scale device designed to reduce intraocular pressure (IOP) by restoring the natural aqueous humor outflow pathways for patients suffering from glaucoma and procedural pharmaceuticals based on an intracameral drug delivery technology designed to reduce IOP by delivering therapeutic levels of glaucoma medication from inside the eye over an extended period of time. Its products include transdermal pharmaceuticals that are applied to the eyelid and designed to treat glaucoma, dry eye, presbyopia and other ocular surface diseases and disorders and micro-invasive, bio-erodible sustained release drug delivery implants to improve the vision of patients.

Revenue in USD (TTM)360.35m
Net income in USD-149.57m
Incorporated1998
Employees907.00

Location
Glaukos Corp1 GLAUKOS WAYALISO VIEJO 92656United StatesUSA
Phone+1 (949) 367-9600
Fax+1 (949) 367-9984
Websitehttps://www.glaukos.com

More ▼

Income statement (USD)

Year on year Glaukos Corp had net income fall 35.75% from a loss of 99.20m to a larger loss of 134.66m despite a 11.26% increase in revenues from 282.86m to 314.71m. An increase in the selling, general and administrative costs as a percentage of sales from 67.35% to 69.54% was a component in the falling net income despite rising revenues.

Explore our tools

Growth CalculatorBETA
Explore the time value of money, the impact of regular contributions, and the power of saving over longer timeframes
Alerts
Create detailed alerts and get notified the moment an event happens
Watchlists
Monitor a select list of assets
Are you sure you want to cancel?
Portfolio
See how trades would have performed from years past or start from the present
Data archive
Download PDF copies of reports from the newspaper markets data page
World markets
View the performance of global markets and browse news items by region
Equities screener
Find companies based on country, sector, and other equity characteristics
Funds overview
View funds that move the market, screen for funds and read relevant news

Data Provided by LSEG

All markets data located on FT.com is subject to the FT Terms & Conditions

All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.

Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.

Glaukos Corp

Select symbol

Glaukos Corp

ApplyActions

Your alerts

About the company